Marina Warner

6.2k total citations
44 papers, 2.5k citations indexed

About

Marina Warner is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Marina Warner has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Medicine, 16 papers in Pharmacology and 13 papers in Epidemiology. Recurrent topics in Marina Warner's work include Antibiotic Resistance in Bacteria (30 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Marina Warner is often cited by papers focused on Antibiotic Resistance in Bacteria (30 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). Marina Warner collaborates with scholars based in United Kingdom, Nepal and Ireland. Marina Warner's co-authors include David M. Livermore, Shazad Mushtaq, Neil Woodford, Michel Doumith, Jiancheng Zhang, Jane F. Turton, Rachel Pike, Michael Carter, Yigong Ge and Alan P. Johnson and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.

In The Last Decade

Marina Warner

39 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Warner United Kingdom 25 2.0k 1.1k 577 563 458 44 2.5k
M. Warner United Kingdom 26 1.8k 0.9× 834 0.8× 579 1.0× 652 1.2× 392 0.9× 38 2.5k
Irene Galani Greece 32 2.6k 1.3× 1.2k 1.1× 800 1.4× 838 1.5× 696 1.5× 77 3.3k
José María Casellas Argentina 17 2.1k 1.1× 669 0.6× 714 1.2× 752 1.3× 619 1.4× 36 2.7k
Simona Bratu United States 24 2.8k 1.4× 1.1k 1.0× 1.0k 1.8× 609 1.1× 702 1.5× 31 3.2k
Samuel K. Bouchillon United States 31 1.9k 1.0× 1.1k 1.0× 425 0.7× 683 1.2× 825 1.8× 51 2.6k
Michael J. Dowzicky United States 33 1.9k 1.0× 887 0.8× 394 0.7× 609 1.1× 687 1.5× 80 2.8k
Ellen Smith Moland United States 29 2.3k 1.2× 655 0.6× 989 1.7× 523 0.9× 485 1.1× 52 2.6k
Demei Zhu China 25 1.3k 0.7× 594 0.6× 387 0.7× 633 1.1× 351 0.8× 65 2.0k
Magdalena A. Taracila United States 33 2.8k 1.4× 1.5k 1.4× 786 1.4× 848 1.5× 507 1.1× 75 3.5k
Laura Zamorano Spain 30 2.3k 1.2× 935 0.9× 549 1.0× 494 0.9× 457 1.0× 67 2.9k

Countries citing papers authored by Marina Warner

Since Specialization
Citations

This map shows the geographic impact of Marina Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Warner more than expected).

Fields of papers citing papers by Marina Warner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Warner. The network helps show where Marina Warner may publish in the future.

Co-authorship network of co-authors of Marina Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Warner. A scholar is included among the top collaborators of Marina Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Warner. Marina Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Livermore, David M., Shazad Mushtaq, Marina Warner, Anna Vickers, & Neil Woodford. (2017). In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 72(5). 1373–1385. 116 indexed citations
2.
Shiu, Winnie Ka Po, John P. Malkinson, M. Mukhlesur Rahman, et al.. (2013). A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. International Journal of Antimicrobial Agents. 42(6). 513–518. 60 indexed citations
3.
Livermore, David M., Marina Warner, & Shazad Mushtaq. (2013). Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococci. International Journal of Antimicrobial Agents. 43(2). 131–134. 3 indexed citations
4.
Moore, Luke, Michel Doumith, Jiancheng Zhang, et al.. (2013). Early (2008–2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. International Journal of Antimicrobial Agents. 42(6). 531–536. 36 indexed citations
5.
Warner, Marina. (2012). Everybody's Joan. London review of books. 34(23). 11–14.
6.
Livermore, David M., et al.. (2011). Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae. International Journal of Antimicrobial Agents. 37(5). 405–409. 19 indexed citations
7.
Livermore, David M., Shazad Mushtaq, Yigong Ge, & Marina Warner. (2009). Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates. International Journal of Antimicrobial Agents. 34(5). 402–406. 69 indexed citations
8.
Warner, Marina. (2008). Activity of Novel Monobactam BAL30072 against Multiresistant Non-Fermenters. 46th Annual Meeting. 3 indexed citations
9.
Warner, Marina. (2008). Activity of cephalosporin CXA-101 (FR264205) with β-Lactamase Inhibitors vs. Enterobacteriaceae. 46th Annual Meeting. 2 indexed citations
10.
Mushtaq, Shazad, Russell Hope, Marina Warner, & David M. Livermore. (2007). Activity of faropenem against cephalosporin-resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 59(5). 1025–1030. 16 indexed citations
11.
Woodford, Neil, Robert L. Hill, Marie-France I. Palepou, et al.. (2007). Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. International Journal of Antimicrobial Agents. 29(4). 456–459. 122 indexed citations
12.
Livermore, David M., Rosy Reynolds, Peter Stephens, et al.. (2006). Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. International Journal of Antimicrobial Agents. 28(4). 273–279. 19 indexed citations
13.
Johnson, Alan P., Theresa Lamagni, Marina Warner, et al.. (2005). Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. International Journal of Antimicrobial Agents. 25(6). 539–541. 1 indexed citations
14.
Livermore, David M., Shazad Mushtaq, & Marina Warner. (2005). Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems. Journal of Antimicrobial Chemotherapy. 55(3). 306–311. 60 indexed citations
15.
Mushtaq, Shazad, Marina Warner, Alan P. Johnson, & David M. Livermore. (2004). Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods. Journal of Antimicrobial Chemotherapy. 54(3). 617–620. 22 indexed citations
16.
Johnson, Alan P., Marina Warner, & David M. Livermore. (2001). Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance. International Journal of Antimicrobial Agents. 17(5). 377–381. 11 indexed citations
17.
Livermore, David M., Marina Warner, Lucinda M. C. Hall, et al.. (2001). Antibiotic resistance in bacteria from magpies ( Pica pica ) and rabbits ( Oryctolagus cuniculus ) from west Wales. Environmental Microbiology. 3(10). 658–661. 50 indexed citations
18.
Johnson, Alan P., C. J. Henwood, Luke Tysall, & Marina Warner. (2001). Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK. International Journal of Antimicrobial Agents. 18(1). 73–76. 10 indexed citations
19.
Johnson, Alan P., Marina Warner, & David M. Livermore. (2000). Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom. Journal of Antimicrobial Chemotherapy. 45(2). 225–230. 61 indexed citations
20.
Warner, Marina. (1997). At the bottom of the garden. TLS, the Times literary supplement/Times literary supplement on CD-ROM/TLS. Times literary supplement. 22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Warner Breakdown of academic impact, for papers by Irene Galani Breakdown of academic impact, for papers by José María Casellas Breakdown of academic impact, for papers by Simona Bratu Breakdown of academic impact, for papers by Samuel K. Bouchillon Breakdown of academic impact, for papers by Michael J. Dowzicky Breakdown of academic impact, for papers by Ellen Smith Moland Breakdown of academic impact, for papers by Demei Zhu Breakdown of academic impact, for papers by Magdalena A. Taracila Breakdown of academic impact, for papers by Laura Zamorano
Rankless by CCL
2026